Reply to thread

My bet's with Gilead. I already placed it. AbbVie is still Abbott, after all. No one makes a decision until the last moment. Higher level management seems too busy trying to stay under the radar. Very little seems to be  accomplished quickly. Cleaning up the bureaucracy pronto will be the deciding factor.  Just deciding to clean it up will take AbbVie too long, let alone actually cleaning it up.